◂ Announcements

Dec 11, 2024ACQUISITIONSwitzerland

Principal Technologies to acquire controlling stake in Syndermix AG

Principal Technologies signed a non-binding LOI to acquire a 70.7% equity interest in Syndermix AG, a Swiss medical research developer, for $44 million. The deal includes three medical technologies.

Value

$44.0M

Status

Announced

ProductsBioEleSonic deviceNoxogen TherapeuticsTheraLect

CompaniesPrincipal Technologies acquirer Syndermix AG target

Sectors#Medical Devices

“The Company will purchase a total 70.7% equity interest in and all loans to Syndermix from two arms-length sellers in a transaction valued at $44 million.”de.advfn.com

1 source
de.advfn.comPRINCIPAL TECHNOLOGIES ANNOUNCES ACQUISTION OF SYNDERMIXPR Newswire (CanadaDec 11, 2024

Summarized from public sources; check the original articles before acting on it.

Similar announcements

Feb 28, 2025ACQUISITIONSwitzerland
Demetra Holding acquires 51% stake in GetSet Surgical
Demetra Holding acquirer GetSet Surgical target medicaldevice-network.com businesswire.com
Nov 15, 2024ACQUISITIONZurich, Switzerland
Myant acquires Nanoleq and Osmotex to expand textile computing
Myant Inc. acquirer Osmotex target newswire.ca prnewswire.com prnewswire.co.uk
Nov 6, 2026ACQUISITIONUnited States$9.90B
Danaher to acquire Masimo for $9.9 billion
Danaher acquirer Masimo target mdtvnow.com
Nov 5, 2026ACQUISITIONUnited States
Curewell Capital to acquire majority stake in ECA Medical
Curewell Capital acquirer ECA Medical target businesswire.com
Nov 5, 2026ACQUISITIONUnited States$538.0M
ZOLL Medical to acquire Itamar Medical for $538M
Asahi Kasei investor ZOLL Medical Corporation acquirer forpressrelease.com
Nov 4, 2026ACQUISITIONPlano, Texas, United States$2.25M
OSTEONIC acquires controlling stake in FoxEyes for 3 billion won
OSTEONIC FoxEyes target en.edaily.co.kr

Loading…